SINOPHARM (01099.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec27

Sinopharm Group will participate in the 92nd National Drug Fair

15:11

A subsidiary of Sinopharm Group has its application for a generic Crisaborole ointment accepted

01:00

Dec26

Sinopharm's Subsidiary Listed as a Distributor for Non-Immunization Program Vaccines in Hubei Province

00:00

Dec25

Sinopharm's Subsidiary, Sinopharm Modern, Obtains Drug Registration Certificate for Quetiapine Fumarate Extended-Release Tablets

14:00

Dec24

Chairman of Sinopharm-affiliated Shandong Medicinal Glass resigns

11:55

Sinopharm's subsidiary platform, Yishu Health, wins Annual Innovation Product award

08:30

Schedules & Filings

Schedules

Filings

Oct21

Earning Release(CST)

FY2025 Q3 Earning Release (HKD) Revenue 158.99 B, Net Income 2.021 B, EPS 3.6093

Aug24

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 158.03 B, Net Income 2.19 B, EPS 0.6995

Aug22

Earning Release(CST)

FY2025 Semi-Annual Earning Release

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change